Sanofi Vaccine Trial
- All
- News
-
France's Sanofi Halts Work On mRNA COVID-19 Vaccine
French pharmaceutical giant Sanofi said Tuesday it was stopping work on an mRNA vaccine against Covid-19 despite positive test results as it lags behind rivals on producing a coronavirus shot.
-
Sanofi, GlaxoSmithKline Get India's Approval For Late-Stage Vaccine Trial
Sanofi SA and GlaxoSmithKline Plc have received an approval from Indian authorities for a late-stage clinical trial of their protein-based COVID-19 vaccine candidate, the drugmakers said on Thursday.
-
Sanofi, GSK Say Covid Vaccine Shows Positive Result
French pharmaceuticals giant Sanofi and Britain's GSK reported Monday positive results in clinical trials of their Covid-19 jab following an earlier setback, raising hope it could be added to the world's vaccine arsenal.
-
Sanofi And GSK Launch Trial For COVID-19 Protein-Based Vaccine
French drugmaker Sanofi and its British peer GSK have started a clinical trial for a protein-based COVID-19 vaccine candidate, as pharmaceutical companies race to develop treatments against the coronavirus pandemic.
-
World's first dengue vaccine beats three virus strains
The world's first vaccine against dengue, developed by French drugmaker Sanofi SA, has shown the ability to protect against disease caused by three of four virus strains in a keenly awaited clinical trial in Thailand.
-
France's Sanofi Halts Work On mRNA COVID-19 Vaccine
French pharmaceutical giant Sanofi said Tuesday it was stopping work on an mRNA vaccine against Covid-19 despite positive test results as it lags behind rivals on producing a coronavirus shot.
-
Sanofi, GlaxoSmithKline Get India's Approval For Late-Stage Vaccine Trial
Sanofi SA and GlaxoSmithKline Plc have received an approval from Indian authorities for a late-stage clinical trial of their protein-based COVID-19 vaccine candidate, the drugmakers said on Thursday.
-
Sanofi, GSK Say Covid Vaccine Shows Positive Result
French pharmaceuticals giant Sanofi and Britain's GSK reported Monday positive results in clinical trials of their Covid-19 jab following an earlier setback, raising hope it could be added to the world's vaccine arsenal.
-
Sanofi And GSK Launch Trial For COVID-19 Protein-Based Vaccine
French drugmaker Sanofi and its British peer GSK have started a clinical trial for a protein-based COVID-19 vaccine candidate, as pharmaceutical companies race to develop treatments against the coronavirus pandemic.
-
World's first dengue vaccine beats three virus strains
The world's first vaccine against dengue, developed by French drugmaker Sanofi SA, has shown the ability to protect against disease caused by three of four virus strains in a keenly awaited clinical trial in Thailand.
